What is Ayass BioScience?
Ayass BioScience, LLC is dedicated to pioneering translational innovation in biology, offering sophisticated clinical laboratory testing and causal biomarker discovery. Leveraging its advanced BiRAGAS and Aptamer platforms, the company aims to provide intelligent biological solutions that move beyond mere correlation to deliver actionable insights. Its services are tailored for the healthcare and research industries, supporting clients in deepening their understanding of complex biological processes and accelerating research and development.
How much funding has Ayass BioScience raised?
Ayass BioScience has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Ayass BioScience?
With the recent influx of capital from a major strategic investment, Ayass BioScience is poised for significant expansion and further development of its innovative platforms. This large-scale, late-stage funding will likely fuel advancements in its biomarker discovery capabilities and the scaling of its clinical laboratory services. The company's focus on providing actionable biological insights positions it for continued growth and impact within the competitive healthcare and research markets, potentially leading to new partnerships and enhanced service offerings.
See full Ayass BioScience company page
